COMPLIANCE INFO_1996-2009 - Laserfiche WebLink

Home Browse Search

STATE OF CALIFORNIA Page 7 DEPARTMENT OF GENERAL SERVICES PROCUREMENT DIVISION Contract (Non -Mandatory) 1-07-65-54-A D) DGS will provide utilization review and approval of eligible Local Agencies. 9. AGENCIES' RESPONSIBILITIES A) Agencies are responsible for accurate and timely completion of Exhibit B, MMCAP's facility membership form. Agencies must return the completed Exhibit B to DGS in order to be enrolled to use this contract. B) If an Agency is not currently enrolled with the State's pharmaceutical wholesale distributor, AmerisourceBergen Drug Corporation, the agency must contact the DGS contract manager to determine eligibility and enroll. C) Agencies shall provide and maintain DEA registration and license (as clinic or pharmacy) by either the State Board of Pharmacy or license as a health care provider by the Department of Public Health. Agencies must provide a copy of current DEA registration and state license to the DGS upon registration or license renewal or other action. D) Agencies must use only those MMCAP contracts which the DGS has authorized Currently the only MMCAP contract authorized by the DGS is the contract with Guaranteed Returns for pharmaceutical reverse distribution and destruction. E) Agencies must not process corrosive and flammable materials in quantities larger than the amount exempted by UPS through this contract. F) Agencies shall ensure available funding for the contract releases/delegation purchase orders they issue. G) Eligible Local Agencies shall contact the DGS and provide applicable licensure to the DGS for utilization review and approval. H) Agencies must complete paperwork and follow procedures as instructed by the returns company. Agencies must complete inventory forms provided by the returns company before shipping. 1) Agencies must comply with federal, state, and local regulations. J) Agencies must comply with HIPAA (Health Insurance Portability and Accountability Act). Agencies must remove any Patient Health Information (PHI) from product destined for reverse distribution or destruction. K) Agencies must provide a DGS assigned agency billing code to the DGS at the time of enrollment.